Literature DB >> 3014595

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.

E A Mueller, D L Murphy, T Sunderland.   

Abstract

To further evaluate the effects and mechanism of action of the putative serotonin agonist m-chlorophenylpiperazine (m-CPP) in humans, changes in plasma prolactin, cortisol, growth hormone, ACTH and body temperature were studied in a group of 10 healthy volunteers following oral administration of m-CPP (0.75 mg/kg), before and after pretreatment with the serotonin receptor antagonist metergoline (MTG). M-CPP produced transient significant increases in plasma prolactin, cortisol, ACTH and in body temperature, but did not significantly alter plasma growth hormone concentration. Moreover, pretreatment with the 5HT antagonist metergoline blocked the m-CPP-induced hormonal and temperature changes. These findings provide strong support for m-CPP's effects in humans being mediated through an interaction with 5HT receptors, and thus support the usefulness of m-CPP as a pharmacologic tool for studying disease and drug-induced alterations in serotonin function in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014595     DOI: 10.1007/bf00174380

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 2.  Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.

Authors:  C Ferrari; E Reschini; M Peracchi; P G Crosignani
Journal:  Gynecol Obstet Invest       Date:  1980       Impact factor: 2.031

3.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

4.  Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  J Clin Endocrinol Metab       Date:  1985-12       Impact factor: 5.958

5.  Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.

Authors:  J A Aloi; T R Insel; E A Mueller; D L Murphy
Journal:  Life Sci       Date:  1984-04-02       Impact factor: 5.037

6.  Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.

Authors:  A Quattrone; G Tedeschi; U Aguglia; F Scopacasa; G F Direnzo; L Annunziato
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.

Authors:  H Y Meltzer; B Uberkoman-Wiita; A Robertson; B J Tricou; M Lowy
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

Review 8.  Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness.

Authors:  S A Checkley
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

9.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.

Authors:  G P Chrousos; H M Schulte; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

10.  Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats.

Authors:  R Samanin; T Mennini; A Ferraris; C Bendotti; F Borsini; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

View more
  18 in total

1.  Does metergoline selectively attenuate 5-HT mediated prolactin release?

Authors:  P M Ellis; S E Gartside; C J Ware; G M Campling; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.

Authors:  R S Kahn; G M Asnis; S Wetzler; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.

Authors:  M Koulu; M Scheinin; A Kaarttinen; J Kallio; K Pyykkö; J Vuorinen; R H Zimmer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers.

Authors:  D L Murphy; E A Mueller; J L Hill; T J Tolliver; F M Jacobsen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

7.  A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects.

Authors:  O Kalus; S Wetzler; R S Kahn; G M Asnis; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 8.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

9.  Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.

Authors:  H Y Meltzer; M Maes
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

10.  Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.

Authors:  M A Lee; J F Nash; M Barnes; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.